Building works underway for new specialist centre that will increase access to cancer care in Western Sydney

SYDNEY, Australia – GenesisCare continues to expand its network of oncology centres, with the start of construction of the Somerset Specialist Centre in Western Sydney. The cancer care provider will be introducing radiation therapy services at the state-of-the-art healthcare hub, once the facility opens in late 2019.

A development consortium, led by Barwon Investment Partners and hospital operator DPA Health, were on site to celebrate the first sod turned on 14 September 2018.

GenesisCare NSW General Manager Ben Ward said: “Patients receiving cancer care deserve the best possible experience, with the best possible outcomes.

“Our comprehensive services will make it simpler and easier for people living in Western Sydney to access world-leading care at the right time. We’re pleased to be working with DPA Health, Barwon, the community and clinicians, to design and deliver full service oncology care at this new facility.”

The Minister for Western Sydney, Stuart Ayres MP, joined the consortium of developers, local community and health representatives, and project staff to watch an excavator break ground.

Minister Ayres said the new hospital will enable clinicians to provide oncology services (medical oncology, radiation oncology and surgery) in the Penrith Local Government Area: “This new and vital facility will allow doctors to confidently invest locally in private rooms and augmented services, ultimately delivering new hospital services and, importantly, integrated cancer treatment for patients in the place they need it most – close to home.

“At the same time it will provide jobs and economic growth for Penrith in line with the Government’s Metropolis of Three Cities vision.”

The centre will feature 6,300 sqm of space for healthcare service providers, including five theatres, 16 private hospital rooms, day treatment facilities, a radiation therapy linear accelerator and a broad range of diagnostic services.

Tom Patrick, Partner from Barwon Investment Partners, said the new facility will enable a high volume of surgery, that was previously redirected or delivered outside of the area, to be handled in Penrith.

“Thanks to this investment in increased capacity for Western Sydney, patients and doctors can now access and provide integrated medical care in their own community, under one roof. This project represents an excellent opportunity for our investors and we are delighted to be able to deploy capital in a manner that will benefit the wider communites of Penrith and Western Sydney.”

Jonathan Edelstein, Director of DPA Health, said rapid population growth has led to record demand on services in Western Sydney.

“We are in a position where cancer patients and specialist doctors are travelling to private facilities in northern, eastern and central Sydney for timely treatment. It is a situation that is not sustainable and an added strain for anyone dealing with the stress of a cancer diagnosis.”

Hacer Group General Manager NSW Quentin Howell said Hacer Group is excited by the opportunity to partner with DPA Health, Barwon Investment Partners and GenesisCare: “Leading the construction of such a well considered and much needed private hospital in Sydney’s west is fantastic opportunity for our NSW business unit.”

With construction now officially underway, the centre is expected to be completed by September 2019.


GenesisCare and Somerset team on the site of the new state-of-the-art healthcare hub in Kingswood, NSW.


The new centre is easily accessible by public transport and the M4 motorway.


What the new centre will look like when it opens in late 2019.

Related articles

Southampton cancer centre awarded ‘Outstanding’ CQC rating

New study shows MRI-guided radiotherapy could double survival rates for people with inoperable pancreatic cancer

Honouring Clinical Excellence & Leadership: GenesisCare Launches Inaugural Global Physician Recognition Program

GenesisCare Appoints Seven Leading Oncologists to Chair its Global Research Committees